BioLineRx Ltd (BLRX)

[PennyWorld]

Dec 12th, 2018 // No Comments

BIOLINERX LTD/S logoBIOLINERX LTD/S (NASDAQ:BLRX) has been given a $2.00 price target by equities research analysts at Maxim Group in a research note issued on Wednesday. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Maxim Group’s target price would suggest a potential upside of 198.55% from the company’s current price.

A number of other equities analysts have also weighed in on the company. HC Wainwright set a $4.00 price objective on BIOLINERX LTD/S and gave the company a “buy” rating in a research note on Wednesday, October 3rd. ValuEngine upgraded BIOLINERX LTD/S from a “hold” rating to a “buy” rating in a research note on Thursday, October 4th. Zacks Investment Research upgraded BIOLINERX LTD/S from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a research note on Thursday, August 16th. Finally, Oppenheimer set a $3.00 price objective on BIOLINERX LTD/S and gave the company a “buy” rating in a research note on Friday, November 9th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $2.50.